Feedback / Questions
Imfinzi (durvalumab) - AstraZeneca, BMS
MEDI0680 - AstraZeneca
AstraZeneca: Q3 2014 Results
(AstraZeneca)
-
Nov 9, 2014 -
Anticipated presentation of P1 data for advanced malignancies at ASCO (May 29-Jun 2, 2015)
Anticipated P1 data
•
Oncology
http://www.astrazeneca.com/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=Content-Disposition&blobheadername2=MDT-Type&blobheadervalue1=inline%3B+filename%3DClinical-trial-programmes-summary.pdf&blobheadervalue2=abinary%3B+charset%3DUTF-8&blobkey=id&blobtable=MungoBlobs&blobwhere=1285682135228&ssbinary=true
Nov 9, 2014
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious